In a new clinical practice guideline issued by the American Academy of Otolaryngology-Head and Neck Surgery Foundation and ...

An estimated 30 million American adults grapple with the discomfort of chronic sinusitis, a condition that makes the simple act of breathing a challenge for about one in eight adults.

Drugs known as tyrosine kinase inhibitors (TKIs) that target BCR-ABL are the most common treatment for CML. These drugs seem to work best when CML is in the chronic phase, but some can also help ...